Evidence map›Paper›PMID 38386661›Full record

ArticlePLoS pathogens2024

Smallpox lesion characterization in placebo-treated and tecovirimat-treated macaques using traditional and novel methods.

Todd M Bell, Paul Facemire, Jeremy J Bearss, Jo Lynne Raymond, Jennifer Chapman, Xiankun Zeng, Joshua D Shamblin, Janice A Williams, Douglas W Grosenbach, Dennis E Hruby and 3 more

Open access · goldAbstract readClinical Trial, Veterinary
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Todd M BellU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland, United States of America.ORCID 0009-0007-6420-3367
Paul FacemireU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland, United States of America.
Jeremy J BearssU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland, United States of America.
Jo Lynne RaymondU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland, United States of America.
Jennifer ChapmanU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland, United States of America.
Xiankun ZengU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland, United States of America.
Joshua D ShamblinU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland, United States of America.
Janice A WilliamsU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland, United States of America.
Douglas W GrosenbachSIGA Technologies, Inc., Corvallis, Oregon, United States of America.
Dennis E HrubySIGA Technologies, Inc., Corvallis, Oregon, United States of America.
Inger K DamonPoxvirus and Rabies Branch, Centers for Disease Control and Prevention (CDC) Atlanta, Georgia, United States of America.
Arthur J GoffU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland, United States of America.
Eric M MuckerU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland, United States of America.
United States Army Medical Research Institute of Infectious Diseases · USSiga Technologies (United States) · USCenters for Disease Control and Prevention · US

Funding

Defense Threat Reduction Agency (DTRA)
6 · The paper itself

Abstract

Smallpox was the most rampant infectious disease killer of the 20th century, yet much remains unknown about the pathogenesis of the variola virus. Using archived tissue from a study conducted at the Centers for Disease Control and Prevention we characterized pathology in 18 cynomolgus macaques intravenously infected with the Harper strain of variola virus. Six macaques were placebo-treated controls, six were tecovirimat-treated beginning at 2 days post-infection, and six were tecovirimat-treated beginning at 4 days post-infection. All macaques were treated daily until day 17. Archived tissues were interrogated using immunohistochemistry, in situ hybridization, immunofluorescence, and electron microscopy. Gross lesions in three placebo-treated animals that succumbed to infection primarily consisted of cutaneous vesicles, pustules, or crusts with lymphadenopathy. The only gross lesions noted at the conclusion of the study in the three surviving placebo-treated and the Day 4 treated animals consisted of resolving cutaneous pox lesions. No gross lesions attributable to poxviral infection were present in the Day 2 treated macaques. Histologic lesions in three placebo-treated macaques that succumbed to infection consisted of proliferative and necrotizing dermatitis with intracytoplasmic inclusion bodies and lymphoid depletion. The only notable histologic lesion in the Day 4 treated macaques was resolving dermatitis; no notable lesions were seen in the Day 2 treated macaques. Variola virus was detected in all three placebo-treated animals that succumbed to infection prior to the study's conclusion by all utilized methods (IHC, ISH, IFA, EM). None of the three placebo-treated animals that survived to the end of the study nor the animals in the two tecovirimat treatment groups showed evidence of variola virus by these methods. Our findings further characterize variola lesions in the macaque model and describe new molecular methods for variola detection.

Indexed as

DermatitisSmallpoxVariola virusAnimalsBenzamidesIsoindolesMacaca fascicularisUnited StatesBenzamidesIsoindoles

Identifiers

PMID38386661
PMCPMC10883539
OpenAlexW4392080059

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.